Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer
(AMEX: MKKGY) Delayed: 30.97 -0.81 (2.55%)
Previous Close $31.78    52 Week High $ 
Open $31.00    52 Week Low $ 
Day High $31.51    P/E N/A 
Day Low $30.92    EPS $ 
Volume 64,579       

Merck & Co. (NYSE: MRK) Delayed: 119.05 -1.71 (1.42%)
Previous Close $120.76    52 Week High $65.46 
Open $121.50    52 Week Low $47.97 
Day High $121.90    P/E 80.99 
Day Low $118.83    EPS $1.47 
Volume 10,927,028       

Merck & Co. (NYSE: MRK) Delayed: 119.05 -1.71 (1.42%)
Previous Close $120.76    52 Week High $65.46 
Open $121.50    52 Week Low $47.97 
Day High $121.90    P/E 80.99 
Day Low $118.83    EPS $1.47 
Volume 10,927,028       

BANK OF AMERICA, STARS LINKED TO THE S&P 500 DUE 4/5/2011 (NYSE: SEO) Delayed: 11.83 --0 (-0%)
Previous Close $11.83    52 Week High $29.87 
Open $1152.15    52 Week Low $9.86 
Day High $11.83    P/E N/A 
Day Low $11.83    EPS $0.00 
Volume 23,583